Nexgen Biofuels (NXGN) Guidance Is Weaker But 14% Bookings Growth Drives PT To $24 - Cantor
Tweet Send to a Friend
Cantor Fitzgerald analyst, Steven Halper, reiterated his Overweight rating on shares of NextGen Healthcare Inc (NASDAQ: NXGN) and raised his ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


